Yamawaki M, Shiraishi J, Sanjo N, Michikawa M, Wada Y
Department of Neurology, Tokyo Medical and Dental University.
Rinsho Shinkeigaku. 1995 Sep;35(9):1044-7.
Recently the incidence of infectious diseases caused by penicillin-resistant Streptococcus pneumoniae (PRSP) is increasing. Patients with meningitis caused by PRSP have been reported with high mortality especially in the field of pediatrics, and it is crucial to treat with accurate and precise choice of antibiotics. We report the first adult case of bacterial meningitis caused by PRSP in Japan. A 32-year-old male without immunological abnormalities developed acute pneumococcal meningitis. Empiric therapy with ampicillin and cefotaxime was not effective and the S. pneumonia from CSF showed resistance to multiple antibiotics such as penicillin and cefotaxime. He was treated successfully with the combination of panipenem/betamipron, vancomycin, and chloramphenicol. We assume that panipenem/betamipron is recommended to be added to empiric therapy of bacterial meningitis, considering an increasing incidence of PRSP infection.
最近,由耐青霉素肺炎链球菌(PRSP)引起的传染病发病率正在上升。据报道,由PRSP引起的脑膜炎患者死亡率很高,尤其是在儿科领域,准确精确地选择抗生素进行治疗至关重要。我们报告了日本首例由PRSP引起的成人细菌性脑膜炎病例。一名32岁无免疫异常的男性患上了急性肺炎球菌脑膜炎。氨苄西林和头孢噻肟的经验性治疗无效,脑脊液中的肺炎链球菌对多种抗生素如青霉素和头孢噻肟耐药。他通过帕尼培南/倍他米隆、万古霉素和氯霉素联合治疗成功康复。考虑到PRSP感染的发病率不断上升,我们认为在细菌性脑膜炎的经验性治疗中建议添加帕尼培南/倍他米隆。